By Dr. Vimal George, MD | Reviewed by CME Travel Academy Faculty8 min read · Reviewed July 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference In this article: Obesity Is Now a Cardiovascular Diagnosis Orforglipron Changes the Access Equation Injectable Incretins Still […]
A primary care guide to stroke secondary prevention: 2021 AHA/ASA guideline, DAPT timing, statin targets, and AFib anticoagulation.
Stroke and TIA Secondary Prevention: A 2026 Primary Care Guide to the AHA/ASA Guideline Read More »
By Dr. Anush Pillai, DO, FAAFP | Reviewed by CME Travel Academy Faculty · 6 min read · Reviewed June 2026 Accredited CME: ✓ AAFP Prescribed ✓ AMA PRA Category 1 Credit™ ✓ AOA Category 2 ✓ 12 Credits per Conference A good family medicine conference does two things at once: it
Family Medicine Conference 2026: A Clinician’s Guide Read More »
By Dr. Vimal George, MD | Reviewed by CME Travel Academy Faculty · 7 min read · Reviewed June 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released its 2026
GOLD 2026 COPD Guidelines: Key Changes for Clinicians Read More »
By Dr. Vimal George, MD | Reviewed by CME Travel Academy Faculty · 7 min read · Reviewed June 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference Most clinicians choose a CME provider the way they pick a flight:
Master the 2022 AHA/ACC/HFSA heart failure guidelines for primary care — ARNI, beta-blocker, MRA, SGLT2i, and new HFpEF therapies including SGLT2 inhibitors and GLP-1 receptor agonists. Earn CME credits.
New CME reporting rules for 2026: real-time tracking, CE Broker pre-verification, Texas SB 912 and the DEA MATE Act — plus a clinician compliance checklist.
KDIGO 2024, the four pillars, and the FLOW & CONFIDENCE trials — what primary care needs to do differently for chronic kidney disease.
Chronic Kidney Disease in Primary Care: The Four Pillars of Kidney Protection Read More »
The 2026 ADA Standards of Care and AACE Type 2 Diabetes Algorithm: earlier CGM, comorbidity-first therapy, and weight targets every clinician should know.
Diabetes Guidelines 2026: The ADA and AACE Updates Every Clinician Needs Read More »
For years, the conversation around GLP-1 receptor agonists in type 2 diabetes centered almost entirely on glucose lowering. Then came a series of landmark cardiovascular outcomes trials — LEADER, SUSTAIN-6, PIONEER 6 — and the paradigm began to shift. But until recently, one practical barrier remained: most GLP-1 receptor agonists required subcutaneous injection, limiting uptake
